image
Healthcare - Drug Manufacturers - General - NYSE - CH
$ 110.86
1.66 %
$ 219 B
Market Cap
18.89
P/E
INCOME STATEMENT
51.7 B REVENUE
10.85%
14.5 B OPERATING INCOME
48.88%
11.9 B NET INCOME
39.28%
EFFICIENCY
Earnings Waterfall Novartis AG
image
Revenue 51.7 B
Cost Of Revenue 12.8 B
Gross Profit 38.9 B
Operating Expenses 24.4 B
Operating Income 14.5 B
Other Expenses 2.6 B
Net Income 11.9 B

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998
REVENUE
Revenue 51 722.0 46 660.0 51 828.0 52 877.0 49 898.0 48 677.0 53 166.0 50 135.0 49 436.0 50 387.0 53 634.0 58 831.0 57 561.0 59 375.0 51 561.0 45 103.0 42 584.0 38 947.0 36 749.0 32 526.0 28 247.0 24 864.0 23 151.0 19 335.0 21 832.0 20 418.0 23 039.2
GROSS PROFIT
Cost Of Revenue 12 827.0 12 472.0 15 486.0 15 867.0 15 121.0 14 425.0 18 407.0 17 175.0 17 520.0 17 404.0 17 345.0 19 608.0 18 756.0 18 983.0 14 488.0 12 179.0 11 439.0 11 032.0 10 299.0 8 868.0 6 625.0 5 894.0 5 441.0 4 759.0 6 245.0 5 229.0 7 305.2
Gross Profit 38 895.0 34 188.0 36 342.0 37 010.0 34 777.0 34 252.0 34 759.0 32 960.0 31 916.0 32 983.0 36 289.0 39 223.0 38 805.0 40 392.0 37 073.0 32 924.0 31 145.0 27 915.0 26 450.0 23 658.0 21 622.0 18 970.0 17 710.0 14 576.0 15 587.0 15 189.0 15 734.0
OPERATING INCOME
Operating Expenses 24 351.0 24 419.0 27 145.0 25 321.0 24 625.0 25 166.0 26 590.0 24 331.0 23 648.0 24 006.0 25 200.0 28 313.0 27 294.0 29 394.0 25 547.0 22 942.0 22 181.0 21 134.0 18 501.0 16 753.0 15 083.0 13 081.0 12 076.0 10 184.0 10 781.0 10 571.0 10 388.1
Selling, General and Administrative Expenses 12 566.0 12 489.0 14 253.0 14 886.0 14 197.0 14 369.0 16 471.0 14 997.0 14 192.0 14 247.0 14 993.0 17 609.0 17 290.0 18 049.0 15 797.0 14 331.0 14 097.0 13 259.0 12 411.0 11 544.0 10 413.0 9 325.0 8 977.0 7 656.0 7 941.0 6 952.0 7 681.0
Research and Development Expenses 10 022.0 11 371.0 9 996.0 9 540.0 8 980.0 9 402.0 9 074.0 8 972.0 9 039.0 8 935.0 9 086.0 9 852.0 9 332.0 9 583.0 9 070.0 7 469.0 7 217.0 6 430.0 5 349.0 4 846.0 4 207.0 3 756.0 3 099.0 2 528.0 2 840.0 2 670.0 2 707.1
Operating Income 14 544.0 9 769.0 9 197.0 26 948.0 10 152.0 9 086.0 8 169.0 8 629.0 8 268.0 8 977.0 11 089.0 10 910.0 11 511.0 10 998.0 11 526.0 9 982.0 8 964.0 6 781.0 7 949.0 6 905.0 6 539.0 5 889.0 5 634.0 4 392.0 4 806.0 4 618.0 5 345.9
PRE-TAX INCOME
Interest Income Expense 1 006.0 855.0 837.0 811.0 869.0 850.0 957.0 777.0 707.0 655.0 704.0 683.0 724.0 751.0 692.0 551.0 290.0 237.0 266.0 294.0 261.0 243.0 259.0 218.0 0 0 0
Total Other Income (904.0) (646.0) 425.0 (16 150.0) (274.0) (146.0) (746.0) (811.0) (451.0) (843.0) 1 183.0 (176.0) (271.0) (225.0) 176.0 (60.0) 94.0 294.0 (219.0) 360.0 (129.0) (155.0) 64.0 367.0 789.0 714.0 408.4
Pre-Tax Income 13 640.0 9 123.0 8 371.0 26 137.0 9 878.0 8 940.0 13 835.0 8 999.0 7 817.0 8 134.0 12 272.0 10 735.0 11 243.0 10 773.0 11 702.0 9 922.0 9 499.0 7 487.0 8 301.0 7 265.0 6 908.0 6 068.0 6 289.0 5 108.0 5 505.0 5 341.0 5 792.2
NET INCOME
Tax Provision 1 701.0 551.0 1 416.0 2 119.0 1 807.0 1 793.0 1 221.0 1 296.0 1 119.0 1 106.0 1 545.0 1 443.0 1 625.0 1 528.0 1 733.0 1 468.0 1 336.0 947.0 1 282.0 1 124.0 1 126.0 1 008.0 1 065.0 869.0 1 110.0 1 153.0 1 366.3
Net Income 11 941.0 14 850.0 6 955.0 24 021.0 8 072.0 7 147.0 12 611.0 7 703.0 6 712.0 17 783.0 10 210.0 9 175.0 9 505.0 9 113.0 9 794.0 8 400.0 8 195.0 11 946.0 7 175.0 6 130.0 5 767.0 5 016.0 5 224.0 4 239.0 4 395.0 4 188.0 4 407.0
EPS 5.97 7.15 3.19 10.7 3.54 3.12 5.44 3.28 2.82 7.4 4.21 3.76 3.93 3.75 4.28 3.7 3.62 5.15 3.06 2.63 2.28 1.99 1.88 1.49 1.7 0.62 0.33